These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

668 related items for PubMed ID: 19061283

  • 21. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K.
    Cancer; 2006 Mar 01; 106(5):1054-64. PubMed ID: 16421920
    [Abstract] [Full Text] [Related]

  • 22. [Triage value of high risk human papilloma virus detection in women with abnormal cervical cytology].
    Jin Y, Pan LY, Wang YF, Cheng XM, Lang JH.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 29; 88(17):1173-6. PubMed ID: 18844110
    [Abstract] [Full Text] [Related]

  • 23. Silent High Grade Cervical Intraepithelial Neoplasia in Atypical Smears from Liquid Based Cervical Cytology - Three Years Experience in Thammasat University Hospital.
    Lertvutivivat S, Chanthasenanont A, Chanthasenanont A, Muangto T, Nanthakomon T, Pongrojpaw D, Bhamarapravatana K, Suwannarurk K.
    Asian Pac J Cancer Prev; 2016 Apr 29; 17(9):4353-4356. PubMed ID: 27797243
    [Abstract] [Full Text] [Related]

  • 24. HPV testing with cytology triage for cervical cancer screening in routine practice.
    Louvanto K, Chevarie-Davis M, Ramanakumar AV, Franco EL, Ferenczy A.
    Am J Obstet Gynecol; 2014 May 29; 210(5):474.e1-7. PubMed ID: 24373948
    [Abstract] [Full Text] [Related]

  • 25. Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer.
    Costa S, Sideri M, Syrjänen K, Terzano P, De Nuzzo M, De Simone P, Cristiani P, Finarelli AC, Bovicelli A, Zamparelli A, Bovicelli L.
    Acta Cytol; 2000 May 29; 44(3):310-8. PubMed ID: 10833984
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.
    Zhao C, Amin M, Weng B, Chen X, Kanbour-Shakir A, Austin RM.
    Arch Pathol Lab Med; 2013 Jul 29; 137(7):942-7. PubMed ID: 23050808
    [Abstract] [Full Text] [Related]

  • 28. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
    Morin C, Bairati I, Bouchard C, Fortier M, Roy M, Moore L, Meisels A.
    J Reprod Med; 2001 Sep 29; 46(9):799-805. PubMed ID: 11584480
    [Abstract] [Full Text] [Related]

  • 29. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
    Ashman D, Zhang H, Li J, Austin M, Wang T, Pradhan D, Zhao C.
    J Am Soc Cytopathol; 2020 Sep 29; 9(6):550-555. PubMed ID: 32475726
    [Abstract] [Full Text] [Related]

  • 30. Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.
    Zhou H, Mody RR, Luna E, Armylagos D, Xu J, Schwartz MR, Mody DR, Ge Y.
    Cancer Cytopathol; 2016 May 29; 124(5):317-23. PubMed ID: 26774025
    [Abstract] [Full Text] [Related]

  • 31. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
    Zhao C, Elishaev E, Yuan KH, Yu J, Austin RM.
    Cancer; 2007 Oct 25; 111(5):292-7. PubMed ID: 17879368
    [Abstract] [Full Text] [Related]

  • 32. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population.
    Leeman A, Del Pino M, Molijn A, Rodriguez A, Torné A, de Koning M, Ordi J, van Kemenade F, Jenkins D, Quint W.
    BJOG; 2017 Aug 25; 124(9):1356-1363. PubMed ID: 28391609
    [Abstract] [Full Text] [Related]

  • 33. Histopathologic follow-up and human papillomavirus DNA test results in 290 patients with high-grade squamous intraepithelial lesion Papanicolaou test results.
    Gao FF, Austin RM, Zhao C.
    Cancer Cytopathol; 2011 Dec 25; 119(6):377-86. PubMed ID: 21774093
    [Abstract] [Full Text] [Related]

  • 34. Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study.
    Derchain SF, Sarian LO, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo RC, Bragança JF, Lima TP, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K.
    J Med Screen; 2008 Dec 25; 15(2):97-104. PubMed ID: 18573778
    [Abstract] [Full Text] [Related]

  • 35. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE, Stoler MH, Wright TC, Sharma A, Wright TL, Behrens CM.
    Lancet Oncol; 2011 Sep 25; 12(9):880-90. PubMed ID: 21865084
    [Abstract] [Full Text] [Related]

  • 36. Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia?
    Adam E, Kaufman RH, Berkova Z, Icenogle J, Reeves WC.
    Am J Obstet Gynecol; 1998 Jun 25; 178(6):1235-44. PubMed ID: 9662307
    [Abstract] [Full Text] [Related]

  • 37. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG, Wright TC, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R.
    J Fam Pract; 1998 Feb 25; 46(2):125-34. PubMed ID: 9487318
    [Abstract] [Full Text] [Related]

  • 38. Assessment of reflex human papillomavirus DNA testing in patients with atypical endocervical cells on cervical cytology.
    Chen L, Yang B.
    Cancer; 2008 Aug 25; 114(4):236-41. PubMed ID: 18548530
    [Abstract] [Full Text] [Related]

  • 39. High-Risk Human Papillomavirus Testing, Genotyping, and Histopathologic Follow-up in Women With Abnormal Glandular Cells on Papanicolaou Tests.
    Zuo T, Levi AW, Lin Q, Abi-Raad R, Adeniran AJ, Cai G.
    Am J Clin Pathol; 2021 Sep 08; 156(4):569-576. PubMed ID: 33728437
    [Abstract] [Full Text] [Related]

  • 40. Health disparities in cervical cancer: Prevalence of high-risk HPV and cytologic diagnoses according to race.
    Miller D, Morris CP, Maleki Z, White M, Rodriguez EF.
    Cancer Cytopathol; 2020 Nov 08; 128(11):860-869. PubMed ID: 32598100
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.